Garrett Fitzpatrick

,

Credentials

MD

Bio

Garrett Fitzpatrick joined LMP April 15, 2024.  He received aanan MD from the University of South Florida College of Medicine and completed an anatomic pathology residency (chief resident 2019-2020) at the University of Florida College of Medicine. He was a neuropathology fellow at the Mayo Clinic and subsequently in LMP.  Fitzpatrick is a member of the American Medical Association, the American Society for Clinical Pathology, and the College of American Pathologists. While a pathology resident, he created the course "Introduction to Histology for Pathologists." 

 

Research Summary

Dr. Fitzpatrick's clinical and research focus is neuropathology

Publications

Yazd HS, Bazargani SF, Fitzpatrick G, Yost RA, Kresak J, Garrett TJ. Metabolomic and lipidomic characterization of meningioma grades using LC-HRMS and machine learning. Journal of the American Society for Mass Spectrometry. 2023 Oct 4;34(10):2187-2198. doi: 10.1021/jasms.3c00158. 

Jonart LM, Ostergaard J, Brooks A, Fitzpatrick G, Chen L, Gordon PM. CXCR4 antagonists disrupt leukaemia- meningeal cell adhesion and attenuate chemoresistance. British Journal of Haematology. 2023. May;201(3):459-469. doi: 10.1111/bjh.18607.

Galvin RT, Zheng C, Fitzpatrick G, Forster CL, Sandoval-Garcia C, Guillaume D, Elbermawy A, Nelson AC, Özütemiz C, Chen L, Moertel CL. MYO5A::FGFR1 represents a novel fusion event in pediatric low-grade glioma. Neurooncology Advances. 2023. Feb 23;5(1):vdad017. doi: 10.1093/noajnl/vdad017.